Gene · 11255
Papers1,482
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,482
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Is pitolisant safe for clinical use? A retrospective pharmacovigilance study focus on the post-marketing safety. | Pharmacol Res Perspect | 2024 | 38174838 | PubTator, text mining | PubMed |
| Molecular mechanism of antihistamines recognition and regulation of the histamine H1 receptor. | Nat Commun | 2024 | 38167898 | PubTator, text mining | PubMed |
| Ligand-directed biased agonism at human histamine H3 receptor isoforms across Gαi/o- and β-arrestin2-mediated pathways. | Biochem Pharmacol | 2024 | 38159685 | PubTator, text mining | PubMed |
| Pharmacological Treatment of Acute Unilateral Vestibulopathy: A Review. | J Audiol Otol | 2024 | 37953517 | PubTator, text mining | PubMed |
| Administration of oxathridine, a first-in-class histamine-3 receptor partial agonist in healthy male volunteers: Central nervous system depression and pseudo-hallucinations. | Br J Clin Pharmacol | 2024 | 37724688 | PubTator, text mining | PubMed |
| Unraveling the complex relationship between prenatal alcohol exposure, hippocampal LTP, and learning and memory. | Front Mol Neurosci | 2023 | 38283699 | PubTator, text mining | PubMed |
| Phenotypical Screening of an MMV Open Box Library and Identification of Compounds with Antiviral Activity against St. Louis Encephalitis Virus. | Viruses | 2023 | 38140657 | PubTator, text mining | PubMed |
| Histamine Receptors: Ex Vivo Functional Studies Enabling the Discovery of Hits and Pathways. | Membranes (Basel) | 2023 | 38132901 | PubTator, text mining | PubMed |
| Synthesis of Pyrrolo[3,4-b]pyridin-5-ones via Ugi-Zhu Reaction and In Vitro-In Silico Studies against Breast Carcinoma. | Pharmaceuticals (Basel) | 2023 | 38004428 | PubTator, text mining | PubMed |
| Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed Treatment: A Case Series. | J Pers Med | 2023 | 38003876 | PubTator, text mining | PubMed |
| Discovery of a Tritiated Radioligand with High Affinity and Selectivity for the Histamine H3 Receptor. | ACS Med Chem Lett | 2023 | 37974943 | PubTator, text mining | PubMed |
Examination of betahistine bioavailability in combination with the monoamine oxidase B inhibitor, selegiline, in humans-a non-randomized, single-sequence, two-period titration, open label single-center phase 1 study (PK-BeST). | Front Neurol | 2023 | 37920833 | PubTator, text mining | PubMed |
| The shared genetic risk factors between Tourette syndrome and obsessive-compulsive disorder. | Front Neurol | 2023 | 37905190 | PubTator, text mining | PubMed |
| Efficacy of the Multi-Target Compound E153 in Relieving Pain and Pruritus of Different Origins. | Pharmaceuticals (Basel) | 2023 | 37895952 | PubTator, text mining | PubMed |
| Linking Migraine to Gut Dysbiosis and Chronic Non-Communicable Diseases. | Nutrients | 2023 | 37892403 | PubTator, text mining | PubMed |
| Structural insights into the agonists binding and receptor selectivity of human histamine H4 receptor. | Nat Commun | 2023 | 37863901 | PubTator, text mining | PubMed |
| Photoswitchable Probes of Oxytocin and Vasopressin. | J Med Chem | 2023 | 37857356 | PubTator, text mining | PubMed |
| The impact of obstructive sleep apnea on nonalcoholic fatty liver disease. | Front Endocrinol (Lausanne) | 2023 | 37850091 | PubTator, text mining | PubMed |
| Melanin: a unifying theory of disease as exemplified by Parkinson's, Alzheimer's, and Lewy body dementia. | Front Immunol | 2023 | 37841274 | PubTator, text mining | PubMed |
Nanodelivery of histamine H3 receptor inverse agonist BF-2649 with H3 receptor antagonist and H4 receptor agonist clobenpropit induced neuroprotection is potentiated by antioxidant compound H-290/51 in spinal cord injury. | Int Rev Neurobiol | 2023 | 37833018 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11255/papers?page=6